As explained before CMS will remain the main supplier of drugs and medical supplies to the public sector. It will be a financially autonomous public organisation. CMS has a revolving fund, established over the past years, which is intended to maintain an adequate balance for the procurement of Pharmaceuticals and supplies. The integrity of this revolving fund is an essential prerequisite for CMS to operate its responsibilities in an adequate financially autonomous way.
From all ministries and institutions to which CMS distributes drugs and medical supplies, the costs should be completely recovered. This means CMS will operate on a cash-and-carry basis. It also means that donor support in the drug sector has to be channelled through the ministries, programmes and institutions, to which the support is targeted.
The plan considers the users (health facilities, DMO's, etc.) of the health services - these services include the drugs - basically to be responsible for their budgeting. If these users are responsible for the control of their budgets, they will have access to the relevant information that enables them to monitor the actual use of their financial resources. This is very important when a requisition based drug supply through the Regional Medical Stores is established, whereby the users can influence the quantities and types of drugs, to be procured.
The availability of drugs at health facility level can be improved by implementation of cost sharing systems related to drugs. The plan anticipates such cost sharing systems to be implemented and gives the PSU a participatory role in the discussions on the design and the implementation of such cost sharing systems.